who knows but regardless of tax benefits or different avenues of commercialisation no one as a rule of thumb gives away something of value for nothing
.and even if they got something for it they would no doubt be able to claim significant tax benefits provided that what they received didn't exceed their total expenditure on the program i would have thought .
- Forums
- ASX - By Stock
- MSB
- Mayne Pharma
Mayne Pharma, page-12
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.52 |
Change
0.055(3.77%) |
Mkt cap ! $1.724B |
Open | High | Low | Value | Volume |
$1.48 | $1.54 | $1.45 | $6.072M | 4.049M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5951 | $1.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.52 | 133644 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1376 | 1.665 |
1 | 13289 | 1.600 |
3 | 6122 | 1.595 |
4 | 18974 | 1.590 |
7 | 5111 | 1.565 |
Price($) | Vol. | No. |
---|---|---|
1.365 | 798 | 1 |
1.435 | 104 | 1 |
1.440 | 11142 | 1 |
1.450 | 10000 | 1 |
1.500 | 40716 | 4 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online